A New Senolytic Enters Human Trials | Lifespan News
Would you like to hear more news stories like this one? If so, head over to LifespanNews for more longevity news, science, and advocacy episodes! Visit / lifespannews .
▼▼ Description, sources, and more below ▼▼
In this episode of Lifespan News:
0:00 Intro
0:37 Regenerating Skin With a Single Protein
1:27 A New Senolytic Enters Human Trials
2:27 T Cell Progenitors Boost Stem Cell Therapy Effectiveness
4:24 Creating Anti-Glucosepane Antibodies
5:41 Big pharma enters senolytic drug discovery program
Visit / brentnally for more of Brent's content!
Executive Producer: Keith Comito
Producer: Nicola Bagalà
Assistant Producer: Sedeer el-Showk
Video Editors: Tim Maupin, Brent Nally
Text Editor: Josh Conway
SOURCES AND FURTHER READING
⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺
Regenerating Skin With a Single Protein:
https://www.lifespan.io/news/regenera...
https://scitechdaily.com/genetic-fact...
https://skinregeneration.org/
A New Senolytic Enters Human Trials:
https://www.lifespan.io/news/a-new-se...
T Cell Progenitors Boost Stem Cell Therapy Effectiveness:
https://www.lifespan.io/news/t-cell-p...
Creating Anti-Glucosepane Antibodies:
https://www.lifespan.io/news/creating...
Big pharma enters senolytic drug discovery program:
https://www.longevity.technology/big-...
HOW YOU CAN SUPPORT US
⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺
If you’d like to help us run this show and/or help Lifespan.io end age-related diseases, you can become a Lifespan Hero: https://lifespan.io/hero. Your support means the world to us!
FOLLOW US EVERYWHERE
⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺
Website: https://lifespan.io/lifextenshow
Instagram: / lifespanio
Facebook: https://facebok.com/lifespanio
Twitter: / lifespanio
Discord: / discord
⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺
#Skin #Type2Diabetes #SenescentCells #ClinicalTrials #Cancer #ImmuneSystem #Glucosepane #AI #Insilico